Introduction {#s1}
============

Stem cells exhibit a remarkable capacity to keep a quiescent undifferentiated state, and then, once activated, contribute to developmental growth or damage tissue regeneration. Over the years, lineage tracing and serial transplantation assays have confirmed the presence of stem cell populations in many tissues in both invertebrate and vertebrate organisms (for reviews, see \[[@bib53]; [@bib49]; [@bib26]\]). These populations include multipotent cells, such as hematopoietic stem cells (HSCs) which can give rise to a broad range of cell types ([@bib32]), and committed precursors, such as the satellite cells required for postnatal growth and the repair of a specific tissue, i.e. skeletal muscle ([@bib10]). Importantly, stem cell activity and capacity to maintain tissue homeostasis depend on a specialized microenvironment called the niche. The stem cell niche was first documented in *Drosophila* ([@bib56]) but it is now widely accepted that all adult stem cells reside within a niche that retains them and regulates their behavior ([@bib53]). Niches range in size and complexity ([@bib36]). They may house a single stem cell, like the follicle stem cell (FSC) niche ([@bib38]), or more than 10 germ stem cells (GSCs), like the testis niche ([@bib54]). Niches may also occupy a single spatially invariant location throughout adult life (e.g. the GSC niche in *Drosophila*), or instead form a complex system of multiple niches distributed throughout tissues (e.g. HSC niches) (for a review, see [@bib36]). Like HSCs, which are able to reside in alternative niches, muscle stem cells (satellite cells) are scattered under the basal laminae of myofibers, which host them and contribute to their niche ([@bib13]; [@bib27]). However, the cellular and molecular mechanisms that control niche occupancy by stem cells remain poorly understood. Recent work on myogenic progenitor cells, which ensure developmental muscle growth but also provide a source of cells that adopt satellite cell position, has shed new light on this issue ([@bib9]). It has been shown that Notch signaling is required for the homing of emerging satellite cells by stimulating them to produce basal lamina, thus promoting their adhesion to myofibers ([@bib9]). Crucially, if the homing process is impaired, satellite cells are unable to receive inductive signals and thus efficiently contribute to muscle growth and regeneration. This makes gaining further insight into the homing of stem cells and their responsiveness to the signals emanating from the niche a key challenge.

We have previously characterized the *Drosophila* muscle stem cells called adult muscle precursors (AMPs) that emerge during mid-embryogenesis and express muscle progenitor-specific markers such as the b-HLH transcription factor Twist ([@bib15], [@bib16]). The AMPs lie dormant during embryonic and most of larval life but once activated they will proliferate to provide a source of myoblasts that ensure adult muscle growth and the regeneration of a subset of thoracic flight muscles. We also followed AMP cells in vivo using membrane-targeted GFP, and found that AMPs send out long cellular processes, and are interconnected ([@bib16]). Interestingly, the capacity to send out cytoplasmic extensions and make interconnections has also been documented for quiescent satellite cells sited on myofibers ([@bib51]). All these features make AMPs similar to vertebrate satellite cells, prompting us to analyze their homing behavior and the mechanisms that drive their activation and exit from the dormant state.

Our data show that emerging AMPs, in addition to long cellular projections, also send out thin filopodia that link them to the neighboring muscles, which behave as AMPs cell niche. We provide genetic evidence that muscles act via dIlp6 to switch the insulin pathway ON in AMPs and initiate AMP reactivation. This leads to a Deltex-involving activation of Notch, which positively regulates AMP proliferation via dMyc.

Results {#s2}
=======

AMPs display homing behavior and become tightly associated with neighboring muscles {#s2-1}
-----------------------------------------------------------------------------------

AMPs are specified at embryonic stage 12 and then remain quiescent and undifferentiated until the mid-second larval instar ([@bib3]). We showed in earlier work that soon after their specification, embryonic AMPs form an interconnected network via long cytoplasmic extensions ([@bib16]). A similar feature has also been reported for the quiescent vertebrate satellite cells, which are connected to each other and to the adjacent muscle through thin cytoplasmic extensions termed 'tunneling nanotubes' ([@bib51]). To examine the dynamics of AMP cell morphology and behavior in more detail, we generated an AMP sensor line, m6-gapGFP (see Materials and methods) that enabled us to visualize the shapes of AMPs in vivo. We focused our analyses on the abdominal AMPs, which when quiescent form a repeat pattern of six cells per hemisegment ([@bib16]). Initially, at embryonic stage 12, AMPs appear spherical in shape and are separated from each other ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}), but a closer view ([Figure 1A](#fig1){ref-type="fig"}) shows that they send out numerous thin filopodia around their surface. This \'sensing behavior\' also persists in later embryonic stages ([Figure 1B,C](#fig1){ref-type="fig"}), in which AMPs become more elongated and send out long cytoplasmic extensions ([Figure 1C](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}) to form an interconnected network ([@bib16]). The long cellular processes follow the main neural branches of the peripheral nervous system (PNS) ([Figure 1C\'](#fig1){ref-type="fig"}, arrows), while the short filopodia display dynamic and irregular patterns and seem not to be attracted by the PNS nerves ([Figure 1C\'](#fig1){ref-type="fig"}, arrowheads).10.7554/eLife.08497.003Figure 1.Quiescent AMP cells are tightly associated with surrounding muscles.(**A, B**) A zoomed view of quiescent dorsal (**A**) and lateral (**B**) AMPs bearing numerous thin filopodia. (**A**) Newly-specified AMPs at embryonic stage 12 display a random pattern of filopodia. (**B**) Mid-stage embryo AMPs become elongated and send out filopodia in an directionally-oriented way. Filopodia pattern of AMPs in m6-gapGFP embryos was revealed by anti-GFP staining of membrane-targeted GFP. (**C**, **C'**) A lateral view of three hemisegments of stage-15 embryo from the sensor driver line m6-gapGFP; Elav-GAL4; UAS-mCD8mCherry, driving mCherry with a membrane localization signal in all neurons. Arrows point to cytoplasmic extensions connecting the AMPs (green) and aligned with the PNS nerves (magenta). Arrowheads denote thin filopodia that are not connected to the PNS nerves. (**D--G**) Dual-color in vivo views of three hemisegments of stage-15 embryos from the m6-gapGFP; Duf-GAL4; UAS-mCD8mCherry line. mCherry (magenta) reveals embryonic muscles and GFP (green) reveals AMPs. Dorsal (**D**), dorsolateral (**E**), lateral (**F**) and ventral (**G**) groups of AMPs are shown. Note that AMPs connect to the embryonic muscles with numerous filopodia. (**D'--G'**) Schemes represent all observed AMP-muscle connections. AMPs connect to a defined set of muscles. (**D**') Dorsal AMP connects to DO1 and DA2 and optionally to DA1 and DO2. (**E'**) Dorsolateral AMPs connect to DT1, DO3, DO4 and DO2. (F') Lateral AMPs connect to SBM, LT1, LT2, LT3 and to LO1 and VL1. (**G'**) Ventral AMP interacts with VA2, VT1 and VA1. Scale bar in (A, B): 4 microns, in (C--G): 9 microns.**DOI:** [http://dx.doi.org/10.7554/eLife.08497.003](10.7554/eLife.08497.003)10.7554/eLife.08497.004Figure 1---figure supplement 1.Segmental pattern of embryonic AMPs.(**A,B**) Pattern of ventral, lateral, dorso-lateral and dorsal AMPs of stage 12 (**A**) and (**B**) stage 15 embryos. Four abdominal hemisegments are shown. Notice that newly specified AMPs at stage 12 (**A**) are of rounded shapes whereas the AMPs at embryonic stage 15 (****B****) adopt elongated and more irregular shapes. Both early and mid stage embryo AMPs produce numerous filopodia. Scale bar: 30 microns.**DOI:** [http://dx.doi.org/10.7554/eLife.08497.004](10.7554/eLife.08497.004)

As the embryonic AMPs are the immediate neighbors of somatic muscles ([@bib15], [@bib16]), we co-visualized the AMPs and the adjacent muscle cells by two-color live cell imaging ([Figure 1D--G](#fig1){ref-type="fig"} and [Video 1](#media1){ref-type="other"}). Our data reveal that the small filopodia sent out by AMPs made contact with surrounding muscles ([Figure 1D-G'](#fig1){ref-type="fig"} and [Video 1](#media1){ref-type="other"}) and by embryonic stage 16 had become tightly associated with neighboring muscles.Video 1.A 3D-reconstruction of the lateral AMPs and surrounding muscles of the stage 15 embryos M6-gapGFP; Duf-GAL4; UAS-mCD8mCherry embryos.Note that all the small filopodia sent by AMPs (green) connect to the muscles (red).**DOI:** [http://dx.doi.org/10.7554/eLife.08497.005](10.7554/eLife.08497.005)10.7554/eLife.08497.005

To characterize AMP localization with respect to internal versus external muscles, we created Z-stack movies of m6-gapGFP embryos ([Video 2](#media2){ref-type="other"} and [Video 3](#media3){ref-type="other"}). We observed that AMPs associate with several rather than just one particular muscle layer. For example, the lateral AMPs extend from the external to internal layer. The posterior lateral AMP (arrows in [Video 2](#media2){ref-type="other"} and [Video 3](#media3){ref-type="other"}) lies externally over the SBM, and is seen at the same level as the external lateral LT muscles. The anterior lateral AMP (arrows in [Video 2](#media2){ref-type="other"} and [Video 3](#media3){ref-type="other"}) lies more internally, mainly at the level of internal lateral muscles LO1 and SBM.Video 2.AMPs localization with respect to external/internal muscle layers in stage 14 embryo.A Z-stack movie of M6-gapGFP embryos stained for muscles (β3-tubulin - magenta) and AMPs (GFP - green). The ventral, lateral, dorso-lateral and dorsal AMPs have distinct internal/external locations. The lateral AMPs (lAMPs) extend from the external to internal layer. The posterior lAMP (arrowhead) lies the most externally and is seen at the same optical level that the external lateral muscles (ExtLM: LT muscles). The anterior lAMP (arrow) lies more internally, mainly at the level of internal lateral muscles (IntLM: LO1 and SBM). The ventral AMPs (vAMPs) are located in between external ventral muscles (ExtVM: VA1 and VA2) and intermediary ventral muscles (ImVM: VO3-VO6) but they send cellular extensions externally and are seen at the level of VA1 and VA2. The dorso-lateral AMPs (dlAMPs) are clearly located under the external DT1 and lie mainly in between the intermediary dorsal muscles (InDM: DO3 and DO4) and internal dorsal muscles (IntDM: DA3). Finally, the dorsal AMPs (dAMPs) are located in between the external (ExtDM: DO1 and DO2) and internal dorsal muscles (IntDM: DA1, DA2). Note: view movie frame by frame to appreciate AMPs positioning and to see corresponding annotations.**DOI:** [http://dx.doi.org/10.7554/eLife.08497.006](10.7554/eLife.08497.006)10.7554/eLife.08497.006Video 3.AMPs localization with respect to external/internal muscle layers in stage 15 embryo.A Z-stack movie of M6-gapGFP embryostained for muscles (β3-tubulin - magenta) and AMPs (GFP - green). Refer to the legend of [Video 2](#media2){ref-type="other"}. Note: view movie frame by frame to appreciate AMPs positioning and to see corresponding annotations.**DOI:** [http://dx.doi.org/10.7554/eLife.08497.007](10.7554/eLife.08497.007)10.7554/eLife.08497.007

To test whether AMP interactions with specific muscles are underpinned by filopodia dynamics, we performed a time-lapse experiment at embryonic stage 15 ([Video 4](#media4){ref-type="other"}). The developmental time-window chosen corresponds to the homing period in which AMPs actively send filopodia and attempt to make contact with target muscles. To follow the number of filopodia and the direction of their projections, we labeled the extremities of all filopodia at each time-point (indicated by yellow circles in [Video 4](#media4){ref-type="other"}). We focused on lateral AMPs and found that they send out filopodia non-randomly and mainly in anterior-dorsal directions, which correlate with the location of SBM and LO/LT muscles to which lateral AMPs are connected. Thus, the filopodia are projected mainly in the direction of targeted muscles, ultimately enabling a subset of them to stabilize (arrowheads in [Video 4](#media4){ref-type="other"}).Video 4.Lifetime imaging of AMPs filopodia dynamics.A lateral view of M6-gapGFP stage 15 embryo is shown. Z-stacks were taken each 1 min during the period of 35 min. The filopodia of lateral AMPs from one segment were annotated. To follow the number of filopodia and the direction of their projection we labeled the extremities of all filopodia at each time point (indicated by yellow open circles). We found that the lateral AMPs send filopodia non-randomly in directions, which correlate with location of muscles to which they are connected by stage 16. We observed that 6 to 9 filopodia are visible at each time point. Some of filopodia appear more stable than others (indicated by arrowheads). Filopodia projecting in dorsal direction (denoted by the arrowhead) does not acquire stable state. Note: A frame by frame viewing of the movie will allow to count number of filopodia per time point and appreciate filopodia extension and retraction events.**DOI:** [http://dx.doi.org/10.7554/eLife.08497.008](10.7554/eLife.08497.008)10.7554/eLife.08497.008

However, reaper-induced muscle ablation experiments ([Figure 2A--D](#fig2){ref-type="fig"}) revealed that there is some plasticity in AMP-muscle interactions. For example, in segments with ablated dorsal and dorso-lateral muscles ([Figure 2B](#fig2){ref-type="fig"}), some of the dorso-lateral AMPs interacted with remaining LT1/2 muscles (arrowhead in [Figure 2B](#fig2){ref-type="fig"}) left unconnected in the wild-type context (arrowhead in [Figure 2A](#fig2){ref-type="fig"}), whereas dorsal AMPs were unable to do so and adopted rounded shapes (yellow arrowheads in [Figure 2B](#fig2){ref-type="fig"}). This finding indicates that dorsal-ventral positional information restricts AMP--muscle contacts. Moreover, we observed AMP cell loss (asterisks in [Figure 2](#fig2){ref-type="fig"}) correlating with the severity of muscle ablation phenotypes (compare [Figure 2B,C and D](#fig2){ref-type="fig"}), which suggests that AMP interactions with muscles are important for their survival.10.7554/eLife.08497.009Figure 2.AMP-muscle connections display spatially-restricted plasticity and are decorated by integrin expression.(**A**) A wild-type view of AMPs and muscles from mid-stage m6-gapGFP embryo. (**B--D**) Similar views from m6-gapGFP;Duf-GAL4;UAS-Rpr embryos with (**B**) weak, (**C**) intermediate, and (**D**) strong muscle ablation phenotypes. In segments with partial loss of lateral muscles, the anterior lateral AMP, which normally extends anteriorly (white arrow in A) remained tightly associated with the posterior lateral AMP and interacted mainly with SBM muscle -- (white arrows in B and C). In segments with loss of dorsal and dorso-lateral muscles and with some lateral muscles persisting, (**B**) the dorso-lateral AMPs interacted with remaining lateral muscles (arrowhead in **B**) to which they do not connect in the wild-type context (arrowhead in **A**). This indicates a degree of plasticity in AMP connections. In segments with a pronounced loss of dorsolateral and lateral muscles (**B** and **C**), the dorsal and dorso-lateral AMPs adopted rounded shapes (yellow arrows) and were unable to migrate to other segments or to the ventral region where muscles were still present. In embryos with total muscle ablation, the majority of remaining AMPs adopted rounded shapes (yellow arrows in **D**). The number of AMPs detected was drastically reduced (asterisks indicate lacking AMPs). (**E**--**H'**) Zoomed views of lateral AMPs stained for (**E-G**') α-PS1 and (**H, H'**) βPS integrin. The first α-PS1 dotty signals associated with AMPs appear at late-stage 14 (**E, E**') and are progressively enriched at stages 15 and 16 (**F-G'**). A punctate α-PS1 pattern is seen, associated with AMP cell bodies (arrowheads) but also aligned with filopodia (arrows in **F**--**G'**). A similar β-PS1 pattern denoted by arrows and arrowheads is also observed, starting from embryonic stage 15 (**H-H'**). Scale bars in (**A-D**): 30 microns; in (**E-G**): 10 microns; in (**H**): 6 microns.**DOI:** [http://dx.doi.org/10.7554/eLife.08497.009](10.7554/eLife.08497.009)

In addition to the filopodia-based contacts, AMP cell bodies appear directly associated with particular muscle fibers. For example, posterior lateral AMP extends over the SBM muscle ([Figure 1F,F\'](#fig1){ref-type="fig"}). This cell-body contact involves the AMP and muscle originating from the common muscle progenitor ([@bib25]), suggesting that a shared lineage might facilitate interactions. Both the filopodia and cell body involving AMP-muscle connections are decorated by punctate expression of a-PS1 and βPS integrin ([Figure 2E--H\'](#fig2){ref-type="fig"}, [Videos 5](#media5){ref-type="other"} and [6](#media6){ref-type="other"}). The first α-PS1 punctate signals associated with the AMP cell body appear at late-stage 14 (arrowhead, [Figure 2E,E\'](#fig2){ref-type="fig"}) and are progressively enriched at stages 15 and 16 ([Figure 2F,G\'](#fig2){ref-type="fig"}, [Videos 5](#media5){ref-type="other"} and [6](#media6){ref-type="other"}). Punctate α-PS1 patterns were associated mainly with the AMP cell bodies (arrowheads in [Figure 2F,G\'](#fig2){ref-type="fig"}, [Videos 5](#media5){ref-type="other"} and [6](#media6){ref-type="other"}) but were also seen to be aligned with filopodia (arrows in [Figure 2F,G\'](#fig2){ref-type="fig"}, [Videos 5](#media5){ref-type="other"} and [6](#media6){ref-type="other"}).Video 5.αPS1 integrin decorates AMP cell bodies and filopodia projections.Two-channel Z-stack movie showing punctate decoration of lateral AMPs by αPS1 integrin at embryonic stage 16. The AMP cell bodies (arrowheads) and filopodia-associated αPS1 dots (arrows) are annotated.**DOI:** [http://dx.doi.org/10.7554/eLife.08497.010](10.7554/eLife.08497.010)10.7554/eLife.08497.010Video 6.αPS1 integrin decorates AMP cell bodies and filopodia projections.Three-channel Z-stack movie showing punctate decoration of lateral AMPs by αPS1 integrin at embryonic stage 16. The AMP cell bodies (arrowheads) and filopodia-associated αPS1 dots (arrows) are annotated. Note: view [Videos 5](#media5){ref-type="other"} and [6](#media6){ref-type="other"} movies in parallel and frame by frame to follow αPS1 dots associated with the AMPs and corresponding annotations.**DOI:** [http://dx.doi.org/10.7554/eLife.08497.011](10.7554/eLife.08497.011)10.7554/eLife.08497.011

Similarly distributed but more discrete β-PS dots were also detected from stage 15 ([Figure 2H,H\'](#fig2){ref-type="fig"}). As filopodia are highly dynamic structures, we posit that integrins mark filopodia subsets that are making contact with target muscles and in the process of stabilization. This hypothesis is supported by in vivo analysis of filopodia dynamics showing that some filopodia indeed get stabilized (arrowheads in [Video 4](#media4){ref-type="other"}).

Taken together, these observations suggest that AMPs like emerging satellite cells ([@bib9]) display homing behavior to muscle niche.

AMPs keep contact with muscle niche during their reactivation {#s2-2}
-------------------------------------------------------------

During larval stages, body wall muscles grow rapidly and increase several times in size, which raises the question of whether AMPs keep associated with the growing larval muscles and whether the long cellular extensions interconnecting the AMPs persist. We found that the interconnecting cellular processes are present in first-instar larval AMPs ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}) but are then progressively lost, becoming undetectable in second instar larvae ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}). However, the filopodia- and cell body-based contacts of AMPs with neighboring muscles persist along larval life until AMP reactivation ([Figure 3B,C](#fig3){ref-type="fig"}). Compared with the late embryonic stage ([Figure 3A](#fig3){ref-type="fig"}), quiescent AMPs at early second larval instar ([Figure 2B](#fig2){ref-type="fig"}) project relatively few filopodia. As shown for lateral AMPs ([Figure 3B](#fig3){ref-type="fig"}), they adopt highly elongated shapes with two long cellular protrusions that extend and follow growing muscle. At this stage, the lateral AMPs restrict their contact to the two closest muscle neighbors, i.e. SBM and LO1, illustrating preferential interactions with these two muscles already seen in embryos.10.7554/eLife.08497.012Figure 3.AMPs stay connected to surrounding muscles until reactivation.(**A**) A dorso-lateral view of two hemisegments in mid-stage embryo showing lateral, dorso-lateral and dorsal AMPs (green) and embryonic muscles (blue). Two lateral AMPs (white and yellow arrows) send numerous filopodia to lateral muscle fibers. Note that one of the lateral AMPs (yellow arrow) extends along the segment border muscle (**SBM**). (**B**) A zoomed view of two lateral AMPs from the early second larval instar. The AMP indicated by the yellow arrow stays connected to the SBM and sends two long cellular extensions (yellow arrowheads) along the SBM. The second lateral AMP (white arrow) still produces filopodia (white arrowheads) linking it with the SBM and the LO1 muscle. The number of filopodia-based AMP-to-muscle connections is reduced compared to embryonic stages. Nuclei of AMPs (red) are revealed by anti-Twi staining. (**C**) A similar view of lateral AMPs from mid-second larval instar undergoing first cellular division. Note that the reactivated AMPs indicated by two white and two yellow arrows keep their extended shapes and filopodia-based connections (white and yellow arrowheads) to the SBM and LO1 muscles. (**D**) Proliferating lateral AMPs from third instar larva labeled with anti-Twist (red) to reveal their nuclei and anti-GFP (green) to reveal their shapes. The remaining cellular extension (yellow arrowhead) is still shown connecting one of lateral AMPs to the SBM muscle. The cells originating from the AMP connected to the LO1 muscle are aligned along this muscle (white arrowhead). Note that proliferating AMPs form clusters of tightly-associated cells. Scale bars in (**A**): 12 microns; in (**B, C**): 25 microns; in (**D**): 36 microns.**DOI:** [http://dx.doi.org/10.7554/eLife.08497.012](10.7554/eLife.08497.012)10.7554/eLife.08497.013Figure 3---figure supplement 1.Larval AMPs adapt their shapes and keep associated to rapidly growing muscles.(**A**) Flat preparation of first-instar M6gapGFP larvae stained for GFP (green) to reveal AMPs and phalloidin (magenta) to label muscles. Notice the elongated shapes of AMPs and persisting interconnections (arrowhead). Arrows indicate two lateral AMPs. (**B**) At second larval instar AMPs continue to elongate and adapt their shapes to keep connected with growing muscles. Arrows point to lateral AMPs among which the anterior one has already divided. (**C**) Nutrient restricted conditions prevent reactivation of AMPs. Arrows point to two lateral AMPs, which keep quiescent in third-instar larvae grown with nutrient restriction. Note that \~16 lateral AMP cells are detected in normal nutrient condition at this stage. Scale bars in (**A, C**): 15 microns; in (**B**): 30 microns.**DOI:** [http://dx.doi.org/10.7554/eLife.08497.013](10.7554/eLife.08497.013)

The observation that the AMPs maintain elongated shapes with long cellular extensions aligning neighboring muscles until the beginning of their reactivation ([Figure 3C](#fig3){ref-type="fig"}) suggests that the association of AMPs with muscle niche could play a role in their exit from the quiescent state. After a few rounds of proliferation, AMPs adopt more rounded shapes ([Figure 3D](#fig3){ref-type="fig"}) but stay closely associated to each other and to the muscle niche ([Figure 3D](#fig3){ref-type="fig"}).

Insulin and TOR signaling pathways positively regulate the reactivation of AMPs from their dormant state {#s2-3}
--------------------------------------------------------------------------------------------------------

The AMPs that are at the origin of adult *Drosophila* muscles are quiescent from mid-embryogenesis until the mid of the second larval instar ([Figure 3](#fig3){ref-type="fig"}). The progenitors of the fly brain, the neuroblasts, also behave quiescently during development, and it has been reported that their exit from the dormant state is subject to a nutritional checkpoint involving the TOR pathway and that glial cell-derived Insulin signals are required to initiate their proliferation ([@bib12], [@bib50]). We observed that AMPs stay quiescently in third-instar larvae growing in nutrient-restricted conditions ([Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}), suggesting that similar mechanisms could also drive their reactivation. To determine the influence of different signaling components on AMP proliferation, we used the AMP-specific driver M6-Gal4 to analyze the impact of signal deregulation by counting the AMPs in synchronized larvae at mid-third instar ([Figure 4](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"} and [Figure 4---source data 1](#SD1-data){ref-type="supplementary-material"}).10.7554/eLife.08497.014Figure 4.Insulin/TOR and Notch pathways control AMP reactivation in larval stages.(**A--I**) Flat preparations of the mid-stage matched third-instar larvae stained for Twist (green) labeling AMP nuclei and stained for Phalloidin (magenta) labeling the larval muscles. The abdominal lateral group of AMPs is shown in (**A**) representative control larva (M6-Gal4) and (**B--I**) in larvae with modified Insulin, TOR, Notch and Myc expression. M6-Gal4 driver is used to AMP-specifically drive the expression of: (**B**) PTEN, an inhibitor of the Insulin pathway; (**C**) InR-CAAX, a constitutively activated form of insulin receptor; (**D**) RHEB, an activator of the TOR pathway; (**E**) TSC1, TSC2, a complex of two proteins that inhibits the TOR pathway; (****F****) NICD, Notch intracellular domain that constitutively activates the Notch pathway; (**G**) dsRNA against Notch transcript; (**H**) overexpression of dMyc; (**I**) dsRNA against dMyc transcript. (****J****) Graphical representation of the mean number of lateral AMPs in the different genetic contexts shown in (**A--I**). (\*\*\*) indicates *P*≤0.001. Scale bar: 36 microns. (**K**) A scheme illustrating the promoter influence of Insulin and Notch pathways and Myc on AMP reactivation.**DOI:** [http://dx.doi.org/10.7554/eLife.08497.014](10.7554/eLife.08497.014)10.7554/eLife.08497.015Figure 4---source data 1.Table showing mean number of dorsal, lateral and ventral AMPs in the abdominal segments from the genotypes shown in [Figure 4A--I](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}.For each genotype, the average number of cells ± standard error mean is shown. Sample size (n) is indicated in brackets [@bib44].**DOI:** [http://dx.doi.org/10.7554/eLife.08497.015](10.7554/eLife.08497.015)10.7554/eLife.08497.016Figure 4---figure supplement 1.Influence of Insulin, TOR, Notch and Numb on AMP cell number in larval stages and in embryos.(**A, B**) Graphs representing the mean number of AMPs from the dorsal and ventral abdominal groups of mid-3rd instar larvae from the genotypes shown in [Figure 4A--I](#fig4){ref-type="fig"}. (\*\*\*), (\*\*) and (\*) indicate *P*≤0.001, *P*≤0.01 and *P*≤0.05, respectively. *P*-values were computed using t test and Prism software with Gal4 as a control sample. (**C-I**) and (**C-II**) Flat preparation of a mid-stage matched Numb-CD2-GFP 3rd-instar larva stained for Numb-GFP (green), Twist (red) and Phalloidin (blue). Note the absence of Numb-GFP in AMPs. (**D**) A graph showing mean number of dorsal, lateral and ventral AMPs from the mid-stage 3rd-instar control larvae (M6-GAL4) and from the larvae with AMP-targeted attenuation of *numb*. (**E**) Lateral views of stage 15 embryos. Targeted activation of Notch (**E-I**), Insulin (**E-II**), and TOR pathway (**E-III**) in AMPs does not lead to precocious reactivation of AMPs in embryos. Embryos are stained for GFP (green) to visualise the AMPs and for proliferation marker PH3 (magenta). Note that no expression of PH3 is seen in AMPs in these contexts. Scale bars in (**C**): 36 microns; in (**E**): 30 microns.**DOI:** [http://dx.doi.org/10.7554/eLife.08497.016](10.7554/eLife.08497.016)10.7554/eLife.08497.017Figure 4---figure supplement 2.M6-Gal4 driver keeps active in Notch attenuation context.Representative images showing m6-driven GFP signal associated with the anterior cluster of lateral AMPs in wt (*lacZ* context) and in larvae with reduced Notch (Notch RNAi context) acquired with the same confocal settings. Graphs of fluorescence intensity made with ImageJ Plot plugin (along the traced lines) are shown below. Notice that mean fluorescence signal in Notch RNAi context when compared to wt is reduced of about 10%.**DOI:** [http://dx.doi.org/10.7554/eLife.08497.017](10.7554/eLife.08497.017)

The AMP-targeted expression of PTEN, which negatively regulates Insulin signaling or TOR inhibitors (TSC1, TSC2), results in dramatically lower numbers of AMPs ([Figure 4B,E,J](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"} and [Figure 4---source data 1](#SD1-data){ref-type="supplementary-material"}). Conversely, we found higher numbers of AMPs following the overexpression of InRCA, a constitutively activated form of the Insulin receptor, or Rheb, the positive modulator of the TOR pathway ([Figure 4D,J](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"} and [Figure 4---source data 1](#SD1-data){ref-type="supplementary-material"}). However, these same components were not sufficient to drive AMP exit from quiescence in the embryonic stages ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"} and [Figure 4---source data 1](#SD1-data){ref-type="supplementary-material"}) and only managed to accelerate AMP entry into proliferation from the mid to early second larval instar. This suggests that Insulin/TOR pathways are part of a more complex regulatory cascade driving the reactivation of dormant AMPs in a developmental time-window restricted to mid-larval stages.

A novel role for Notch and dMyc in promoting AMP proliferation {#s2-4}
--------------------------------------------------------------

We previously reported that a regulatory element of *Enhancer of split m6 (E(spl)m6; m6)* gene carrying potential Supressor of Hairless (Su (H)) binding sites ([@bib46]) drives expression specifically in quiescent AMPs ([@bib16]). This suggests that the Notch pathway is activated in embryonic AMPs, but the question of whether it plays a role in setting quiescent versus proliferative AMP state remained unsolved. Here, we showed that m6-Gal4-targeted expression of the Notch intracellular domain (NICD) in embryonic AMPs does not alter their quiescence in embryos ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). However, in the same NICD context, there were significantly higher numbers of AMPs in third-instar larvae, suggesting that Notch reactivates AMPs in larval stages and promotes their proliferation ([Figure 4F,J](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"} and [Figure 4---source data 1](#SD1-data){ref-type="supplementary-material"}). The reduced number of AMPs in larvae with m6-driven Notch attenuation ([Figure 4G,J](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"} and [Figure 4---source data 1](#SD1-data){ref-type="supplementary-material"}) further supports this observation. As the decrease in AMP numbers in a Notch-RNAi context has not been associated with a reduced level of GFP driven by the same m6 regulatory element ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}), we hypothesize that a low Notch level is sufficient to maintain m6 activity but we cannot rule out a possibility that perdurance of Gal4 and GFP in larval stages plays role as well.

In vertebrate satellite cells, Notch regulates the asymmetric divisions controlling the number of reserve muscle stem cells that, at the end of the cell cycle, sit on muscles and remain undifferentiated ([@bib27]). The activated AMPs do not seem to divide asymmetrically, as they did not increase in number in the *numb* RNAi context ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}) and no reactivated AMPs were found to express the asymmetric cell division marker Numb-CD2-GFP ([@bib45]) ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Notch thus plays a novel role in AMPs, promoting their proliferation without driving asymmetric cell divisions.

Besides the Insulin and Notch pathways, a recent study ([@bib28]) found that in vertebrates the transcription factor Myc is also involved in regulating myoblast proliferation during muscle development and regeneration. This prompted us to test whether Myc also regulated the proliferation of AMPs. Indeed, dMyc acts as a positive regulator of AMP reactivation ([Figure 4H--K](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"} and [Figure 4---source data 1](#SD1-data){ref-type="supplementary-material"}), thus providing evidence that the proliferation of muscle stem cells is regulated by the same set of genes in both *Drosophila* and vertebrates.

Notch acts downstream of the Insulin pathway and regulates the proliferation of AMPs via dMyc {#s2-5}
---------------------------------------------------------------------------------------------

To gain a better understanding of the functional link between Insulin, Notch and dMyc in AMP cell behavior, we analyzed their activity in reactivated AMPs. We first tested whether activation of the Insulin pathway was correlated with AMP proliferation. It has been reported that the plekstrin homology (PH) domain containing t-PGH protein binds specifically to phosphatidylinositol-3,4,5-P3 (PIP3) and, if localized to plasma membrane, indicates PI3K/Insulin pathway activity ([@bib7]). We thus used transgenic t-PGH larvae to follow subcellular t-PGH localization in reactivated AMPs. The data show that t-PGH is specifically recruited to plasma membrane in AMPs that undergo cell divisions ([Figure 5A- A\"](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Importantly, the proliferating AMPs also display high levels of intracellular Notch and nuclear dMyc ([Figure 5B--B\'\'](#fig5){ref-type="fig"}), showing that activation of the Insulin pathway and increased Notch and dMyc levels correlate with the reactivated AMPs state.10.7554/eLife.08497.018Figure 5.Myc acts downstream of Insulin and Notch pathways during AMP reactivation.(**A, A"**) A single cluster of AMPs from the tPGH third-instar larvae stained for GFP to reveal activation of PI3K/Insulin pathway and for phospho-histone H3 (PH3) to identify AMPs that undergo proliferation. Note that PH-GFP localizes to the cell membranes, indicating the activity of PI3K/Insulin signaling in AMPs that proliferate. (**B--D"**) Single clusters of third-instar larva lateral AMPs stained for dMyc and NICD (**B--C"**) and for dMyc and Lamin (**D--D''**). (**B, B"**) Control m6-GAL4 larva. (**C, C"**) m6-GAL4-driven expression of Inr-CAAX in AMPs upregulates dMyc and NICD expression. (**D, D"**) Targeted expression of NICD in AMPs results in an increased dMyc signal in AMPs. (**E--I**) Double transgenic mutant contexts and their effects on number of lateral AMPs. Attenuations of Notch (**F**) and dMyc (**G**) rescue the InRCA-induced overproliferation phenotype. Similarly, attenuating dMyc in AMPs expressing NICD dramatically reduces AMP numbers (**I**) compared to NICD context (**H**). (**J**) Mean fluorescence intensity of the dMyc signal detected in loss- and gain-of-function contexts for Insulin and Notch pathway components. (**K**) Mean fluorescence intensity of the NICD signal detected in InRCA and PTEN contexts. (**L**) Mean number of lateral AMPs counted in different genetic contexts shown in (**E--I**). (\*\*\*) and (\*\*) indicate *P*≤ 0.001 and *P*≤ 0.01, respectively. Scale bars are (**A, A"**): 9 microns; (**B--D"**): 15 microns; (**E--I**): 45 microns. (**M**) Schematic illustration of genetic hierarchy between Insulin, Notch and Myc during AMP reactivation.**DOI:** [http://dx.doi.org/10.7554/eLife.08497.018](10.7554/eLife.08497.018)10.7554/eLife.08497.019Figure 5---source data 1.Table showing mean number of dorsal, lateral and ventral AMPs in the abdominal segments from the genotypes shown in [Figure 5E--I,L](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}.For each genotype, the average number of cells ± standard error mean is shown. Sample size (n) is indicated in brackets. Below a table with mean signal intensity measurements for Myc and NICD in lateral AMP cluster from the genotypes shown in [Figure 5B--D\'\',J,K](#fig5){ref-type="fig"}. For each genotype, the average signal intensity value ± standard error mean is shown. Sample size (n) is indicated in brackets.**DOI:** [http://dx.doi.org/10.7554/eLife.08497.019](10.7554/eLife.08497.019)10.7554/eLife.08497.020Figure 5---figure supplement 1.Proliferation of AMPs is positively regulated by Insulin, Notch and their downstream target Myc.(**A**) A graph representing the mean number of AMPs from the dorsal and ventral abdominal groups of mid-third-instar larvae from the genotypes shown in [Figure 5E--I](#fig5){ref-type="fig"}. Notice that ventral AMPs reactivation appears independent of Insulin and Notch but dependent on Myc. (\*\*\*) and (\*\*) indicate *P*≤0.001 and *P*≤0.01, respectively. *P*-values were computed using t test and Prism software with Gal4 as a control sample. (**B-D**) A single cluster of AMPs from the lateral group of M6-gapGFP early third-instar larvae stained for GFP (green) visualizing the AMPs and for proliferation marker PH3 (magenta). (**E-E"**) Cluster of lateral AMPs from early third-instar t-PGH larvae stained for GFP, gray (**E**) to reveal subcellular PGH localisation and (**E'**) for PH3 (magenta). (**E"**) merged view. Arrow indicates membrane localized PGH in cell with a high level of PH3 and arrowhead points to a cell with faint PH3 staining and with ubiquitously distributed PGH. Scale bar in (**B**): 15 microns; in (**E**): 9 microns.**DOI:** [http://dx.doi.org/10.7554/eLife.08497.020](10.7554/eLife.08497.020)

We then tested whether the Insulin pathway acted upstream of Notch and dMyc. First, we quantified the level of Notch and dMyc in the individual lateral AMPs, and found that the mean fluorescent intensity representing Notch and dMyc protein levels was increased in the InRCA context ([Figure 5C,C\",J,K](#fig5){ref-type="fig"} and [Figure 5---source data 1](#SD2-data){ref-type="supplementary-material"}) compared with wild-type ([Figure 5B,B\'\',J,K](#fig5){ref-type="fig"} and [Figure 5---source data 1](#SD2-data){ref-type="supplementary-material"}) and was significantly lower in the AMPs expressing the negative regulator of Insulin signaling PTEN ([Figure 5J,K](#fig5){ref-type="fig"} and [Figure 5---source data 1](#SD2-data){ref-type="supplementary-material"}). The Insulin pathway thus positively regulates Notch and dMyc during AMP reactivation. Next, using the same approach, we tested dMyc protein levels in AMP-targeted gain and loss of Notch function, and found that Notch increased nuclear dMyc levels ([Figure 5D,D\'\'](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"} and [Figure 5---source data 1](#SD2-data){ref-type="supplementary-material"}), suggesting that Notch acts upstream of dMyc. The sum of these observations prompted us to determine whether dMyc acted as an effector of Insulin and Notch pathways, and whether Notch functioned downstream of Insulin during AMP proliferation. We found that lowering Notch or dMyc levels in AMPs expressing InRCA led to an attenuation of the AMP overproliferation phenotype, indicating that both Notch and dMyc act downstream of the Insulin pathway ([Figure 5E--G,L, M](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"} and [Figure 5---source data 1](#SD2-data){ref-type="supplementary-material"}). We also observed that the increased number of AMPs generated in the NICD-overexpressing context was dMyc-dependent ([Figure 5H,I,L, M](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"} and [Figure 5---source data 1](#SD2-data){ref-type="supplementary-material"}), indicating that dMyc acts as an effector of Notch in reactivated AMPs. Taken together, these data establish an Insulin-Notch-dMyc cascade governing the exit of AMPs from the dormant state and promoting their proliferation ([Figure 5M](#fig5){ref-type="fig"}). However, as NICD overexpression induces higher numbers of AMPs than InRCA overexpression ([Figure 5L](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"} and [Figure 5---source data 1](#SD2-data){ref-type="supplementary-material"}), we cannot rule out the possibility that Notch also acts in an InR-independent way.

Deltex-involving activation of Notch downstream of the Insulin pathway promotes AMP proliferation {#s2-6}
-------------------------------------------------------------------------------------------------

The increased levels of intracellular Notch in AMPs expressing the activated form of Insulin receptor (InRCA) suggested that Insulin promotes Notch pathway activity during AMP reactivation. A similar observation was recently reported in *Drosophila* intestinal stem cells in which proliferation and differentiation is finely tuned by the interplay between the Insulin and Notch pathways ([@bib17]). However, the issue of whether the Insulin-dependent regulation of Notch involves conventional Delta/Serrate signal transduction has never been addressed. We thus tested whether the attenuation of Delta or Serrate in the muscle or PNS cells with which AMPs are associated impacts on AMP proliferation ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"} and [Figure 6---source data 1](#SD3-data){ref-type="supplementary-material"}). We found that knocking down Notch ligands in direct AMP cell neighbors has no effect on AMP reactivation ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"} and [Figure 6---source data 1](#SD3-data){ref-type="supplementary-material"}). Similarly, expressing in AMPs a dominant-negative form of Notch receptor (ECN) devoid of intracellular domain and known to efficiently repress canonical Notch signaling ([@bib44]) had no effect on AMP cell numbers ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"} and [Figure 6---source data 1](#SD3-data){ref-type="supplementary-material"}), suggesting that Notch activation in AMPs could occur in a ligand-independent way. To further explore the Insulin-Notch pathway linkage, we tested the expression of the ubiquitin ligase Deltex, which is known to play a role in ligand-independent intracellular activation of Notch by promoting its mono-ubiquitinated state ([@bib22]). We found that punctate cytoplasmic Deltex expression increased significantly in AMPs expressing InRCA compared to the control ([Figure 6A--C](#fig6){ref-type="fig"} and [Figure 6---source data 1](#SD3-data){ref-type="supplementary-material"}). Consistently with this observation, targeted expression of Deltex in AMPs or attenuation of its repressor Supressor of Deltex (Su (Dx)) both led to an overproliferation phenotype ([Figure 6D,E,I](#fig6){ref-type="fig"} and [Figure 6---source data 1](#SD3-data){ref-type="supplementary-material"}). [@bib22] proposed that non-visual β-arrestin homolog Kurtz (Krz) binds together with Deltex to the Notch receptor, leading to its poly-ubiquitination and subsequent degradation. We tested Krz function in AMPs and found that both increasing and decreasing Kurtz levels leads to overproliferation of AMPs ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"} and [Figure 6---source data 1](#SD3-data){ref-type="supplementary-material"}). This suggested that the stoichiometry of Krz and Dx levels regulates Notch activation in AMPs (see schemes in [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). Indeed, reducing Deltex by RNAi-based attenuation or by overexpressing Su (Dx) led to an increased number of AMPs ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"} and [Figure 6-source data 1](#SD3-data){ref-type="supplementary-material"}) similar to that observed in the Deltex overexpression context ([Figure 6D,I](#fig6){ref-type="fig"} and [Figure 6---source data 1](#SD3-data){ref-type="supplementary-material"}), whereas simultaneous overexpression of Deltex and Kurtz had no effect on AMP numbers ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"} and [Figure 6---source data 1](#SD3-data){ref-type="supplementary-material"}). It has also been reported that Shrub, a component of the ESCRT-III complex that promotes Notch degradation in multivesicular bodies (MVBs), acts as a negative regulator of ligand-independent Notch activity ([@bib22]). We thus tested whether Shrub attenuation could promote AMP proliferation. We found that a downregulation of Shrub in AMP cells results in a burst of AMP proliferation ([Figure 6F,I](#fig6){ref-type="fig"} and [Figure 6---source data 1](#SD3-data){ref-type="supplementary-material"}). Consistent with all these data, overexpressing Deltex or Kurtz in InRCA context increased AMP cell numbers compared to InRCA alone ([Figure 6G,I](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"} and [Figure 6---source data 1](#SD3-data){ref-type="supplementary-material"}). On the other hand, overexpressing Deltex in AMPs in which the Insulin pathway was attenuated by PTEN restored AMP proliferation back up to wild-type levels ([Figure 6H,I](#fig6){ref-type="fig"} and [Figure 6---source data 1](#SD3-data){ref-type="supplementary-material"}). Taken together, this body of evidence suggests that during AMP reactivation, the Insulin pathway activates Notch in a Deltex and Shrub-involving ligand-independent way.10.7554/eLife.08497.021Figure 6.Insulin-driven Notch activation in AMPs involves Deltex.(**A-B'**) Single clusters of third-instar larva lateral AMPs stained for Deltex and GFP. (**A--A'**) There is greater punctate Deltex expression in AMPs expressing constitutively activated InR than in control larva (**B-B'**) expressing *lacZ*. (**C**) Mean fluorescence intensity of the Deltex signal detected in gain-of-function context for Insulin *versus* wild-type. (**D-F**) Components of ligand-independent Notch activation have impacts on AMP cell numbers. AMP-targeted expression of Deltex (**D**), attenuation of Su (Deltex) (**E**) or attenuation of Shrub (**F**) all lead to an AMP overproliferation phenotype. The key role of Deltex as an activator of AMP proliferation is confirmed by an increased number of AMPs in embryos with M6-targeted expression of InRCA and Deltex (**G**) and further supported by partial rescue of AMP number when co-expressing Deltex with the PTEN Insulin pathway inhibitor (**H**). (**I**) Graphical representations of mean number of lateral AMPs in genetic contexts shown in (**D-H**). (\*\*\*) indicates *P* ≤ 0.001. Scale bars are (**A, B'**): 15 microns; (**D--H**): 45 microns.**DOI:** [http://dx.doi.org/10.7554/eLife.08497.021](10.7554/eLife.08497.021)10.7554/eLife.08497.022Figure 6---source data 1.Table showing mean number of AMPs in the abdominal segments from the genotypes shown in [Figure 6D--I](#fig6){ref-type="fig"} and [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"} and [2](#fig6s2){ref-type="fig"}.For each genotype, the average number of cells ± standard error mean is shown. Sample size (n) is indicated in brackets. Below, a table with mean Deltex signal intensity measurements in lateral AMP cluster from the genotypes shown in [Figure 6A--C](#fig6){ref-type="fig"}. For each genotype, the average signal intensity value ± standard error mean is shown. Sample size (n) is indicated in brackets.**DOI:** [http://dx.doi.org/10.7554/eLife.08497.022](10.7554/eLife.08497.022)10.7554/eLife.08497.023Figure 6---figure supplement 1.Ligand independent activation of Notch promotes proliferation of AMPs.(**A**) A scheme representing potential sources of Notch ligands (Delta and Serrate). Notch signalling requires cell-cell contact and is activated in AMPs downstream of Insulin. This implies that the activated AMP cell (surrounded by red line) via so far unknown signal X promotes Delta or Serrate expression in cells that are direct AMP neighbours: PNS neurons (in yellow) or muscles (in blue). (**B**) Notch ligands attenuation in PNS neurons or in muscles and AMP-targeted expression of dominant-negative form of Notch receptor (that binds to ligand but is lacking intracellular domain and thus is unable to activate Notch targets) have no impact on AMP cell number suggesting that Notch activation in AMPs downstream of Insulin receptor is ligand independent.**DOI:** [http://dx.doi.org/10.7554/eLife.08497.023](10.7554/eLife.08497.023)10.7554/eLife.08497.024Figure 6---figure supplement 2.Role of Kurtz and Deltex in reactivation of AMPs.(**A**) Levels of Deltex versus Kurtz play important role in ligand independent activation of Notch during reactivation of AMPs. Notice that attenuation of Kurtz or Deltex results in an increased number of AMPs whereas simultaneous over-expression of Kurtz and Deltex has no effect on AMP cell number. Schemes below illustrate effects of Deltex and Kurtz levels on Notch activation in an AMP activated by the Insulin pathway. Scale bar: 30 microns. (**B**) A graph representing the mean number of lateral AMPs of mid third-instar larvae from the genotypes shown in (**A**) and larvae over expressing in AMPs Su (Deltex), Kurtz and those overexpressing both InrCA and Kurtz. (\*\*\*) indicates *P*≤0.001. *P*-values were computed using t test and Prism software with Gal4 as a control sample except those linked on the graph.**DOI:** [http://dx.doi.org/10.7554/eLife.08497.024](10.7554/eLife.08497.024)

Muscle niche-derived dIlp6 reactivates AMPs {#s2-7}
-------------------------------------------

The specific role of the Insulin pathway in the proliferation of AMPs suggested it was induced by locally-secreted Insulin receptor ligands, the Insulin-like peptides (dIlps). We first tested mutants for *dIlp2, dIlp5* and *dIlp6* ([@bib21]) and found that AMP proliferation was only inhibited in a *dIlp6* loss-of-function background ([Figure 7A--C,J](#fig7){ref-type="fig"}, [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"} and [Figure 7---source data 1](#SD4-data){ref-type="supplementary-material"}). To identify the source of the dIlp6, we expressed a dominant-negative (DN) form of *Drosophila* dynamin protein called Shibire (Shi-DN) in larval muscles, neural cells and glial cells ([Figure 7D--F,J](#fig7){ref-type="fig"}, [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"} and [Figure 7---source data 1](#SD4-data){ref-type="supplementary-material"}). Shi-DN affects vesicular trafficking and thus inhibits the secretion of signaling molecules from the cell ([@bib48]). We found that blocking the secretion from larval muscles affected the proliferation of AMPs and reduced their numbers ([Figure 7D](#fig7){ref-type="fig"}, [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"} and [Figure 7---source data 1](#SD4-data){ref-type="supplementary-material"}), whereas no effect was observed when Shi-DN was expressed in either neural cells ([Figure 7E,J](#fig7){ref-type="fig"}, [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"} and [Figure 7---source data 1](#SD4-data){ref-type="supplementary-material"}) or glial cells ([Figure 7F,J](#fig7){ref-type="fig"}, [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"} and [Figure 7---source data 1](#SD4-data){ref-type="supplementary-material"}). A key role of muscles in producing dIlp6 and inducing AMP proliferation is further supported by the reduction of AMP numbers in larvae with attenuated *dIlp6* expression in muscles but not in glial cells ([Figure 7G,I,J](#fig7){ref-type="fig"}, [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"} and [Figure 7---source data 1](#SD4-data){ref-type="supplementary-material"}). Conversely, an increased number of AMPs was detected in muscle-specific overexpression of dIlp6 ([Figure 7H,J](#fig7){ref-type="fig"}, [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"} and [Figure 7---source data 1](#SD4-data){ref-type="supplementary-material"}). To understand the link between persisting cellular extensions and reactivation of AMPs, we attempted to modulate filopodia formation by attenuating the *DAAM* gene encoding one of formins known to be involved in filopodia dynamics at axon growth cones ([@bib20]). We found that *DAAM*-attenuation leads to an altered AMP proliferation in third-instar larvae ([Figure 7M](#fig7){ref-type="fig"} and [Figure 7---source data 1](#SD4-data){ref-type="supplementary-material"}) that correlates with reduced length of cellular protrusions observed in *DAAM*-RNAi second-instar larvae ([Figure 7L](#fig7){ref-type="fig"}, compare to wild-type shown in [Figure 7K](#fig7){ref-type="fig"}).10.7554/eLife.08497.025Figure 7.Larval muscles regulate AMP proliferation via Insulin-like peptide dIlp6.(**A--I**) Flat preparations of the mid-stage matched third instar larvae stained for Twist (green) labeling AMP nuclei and Phalloidin (magenta) labeling larval muscles. One abdominal lateral group of AMPs is shown. (**A**) Larvae mutant for *dIlp6 (Df-Ilp6)* shows a lower AMP count. (**B, C**) No changes in AMP number are observed in *dIlp2* or *dIlp5* mutant larvae. (**D**) Muscle-targeted expression of the dominant-negative form of *shibire (DN-shi)* leads to a decrease in AMP cell number. (**E, F**) Elav-Gal4-driven expression of *DN-shi* in neural cells or Repo-Gal4-driven expression in glial cells have no effects on AMP number. (**G**) Attenuation of *dIlp6* in larval muscle leads to a decrease in AMP number while (**H**) muscle-specific gain-of-function of *dIlp6* leads to an increase in AMP number. (**I**) No change in AMP number is observed after RNAi-based attenuation of *dIlp6* in glial cells. (**J**) Mean number of lateral AMPs counted in different genetic contexts shown in A--I and O. (\*\*\*) indicates *P*≤0.001. (**K**) Posterior lateral AMP revealed by GFP staining (green) of M6-gapGFP second-instar larvae. Arrows indicate long AMP filopodia extending along the segment border muscle (Phalloidin staining, in magenta). (**L**) A similar view of posterior lateral AMP from second instar DAAM-RNAi larvae. Arrows point to short filopodia. (****M****) Reduced AMP numbers in third instar larvae induced by M6-targeted attenuation of DAAM. Scale bar in (**A--I**) and (**O**): 45 microns; in (**M, N**): 25 microns.**DOI:** [http://dx.doi.org/10.7554/eLife.08497.025](10.7554/eLife.08497.025)10.7554/eLife.08497.026Figure 7---source data 1.Table showing mean number of dorsal, lateral and ventral AMPs in the abdominal segments from the genotypes shown in [Figure 7A--L](#fig7){ref-type="fig"} and [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}.For each genotype, the average number of cells ± standard error mean is shown. Sample size (n) is indicated in brackets.**DOI:** [http://dx.doi.org/10.7554/eLife.08497.026](10.7554/eLife.08497.026)10.7554/eLife.08497.027Figure 7---figure supplement 1.Muscle released dIlp6 is required for the activation of dorsal and lateral but not ventral AMPs.(**A, B**) Graphical representation of mean number of AMPs from the dorsal and ventral abdominal groups of mid third-instar larvae for the genotypes shown in [Figure 7A--L](#fig7){ref-type="fig"}. Notice that muscle released signal is required for activation of both dorsal and ventral AMPs; however, dIlp6, which is required for Insulin pathway activation in lateral and dorsal AMPs, has no effect on ventral AMPs. (\*\*\*) indicates *P*≤0.001. *P*-values were computed using t test and Prism software with different control samples: wt (Canton S) for dIlp deficiencies, Mef-Gal4 for Mef-driven genotypes, Elav-Gal4, for Elav-driven genotypes, and Repo-Gal4 for Repo-driven genotypes.**DOI:** [http://dx.doi.org/10.7554/eLife.08497.027](10.7554/eLife.08497.027)

Taken together, the data suggest that muscle behaves as an AMP niche and plays a driving role in AMP reactivation in later larval life (see AMP reactivation scheme, [Figure 8](#fig8){ref-type="fig"}).10.7554/eLife.08497.028Figure 8.Niche role of muscle in AMP reactivation.Scheme illustrating the muscle niche-induced Insulin/Notch/dMyc cascade governing the reactivation of dormant AMPs. During embryonic stages, quiescent AMPs send out filopodia and make contact with neighboring muscles. These AMP-to-muscle ties persist until the AMPs are reactivated at mid-second larval instar, facilitating the reception of the inductive dIlp6 signal emitted by the muscle niche. In reactivated AMP (depicted in red), activation of the Insulin pathway leads to a Deltex-involving activation of Notch and induces AMP proliferation through the Notch target Myc.**DOI:** [http://dx.doi.org/10.7554/eLife.08497.028](10.7554/eLife.08497.028)

Discussion {#s3}
==========

How the stem cells specified during development keep their non-differentiated quiescent properties and how they are reactivated from their dormant state remain central challenges in stem cell biology. Here, we applied a *Drosophila* model to analyze cellular and molecular events underpinning Adult Muscle Precursor (AMP) reactivation from the dormant state, and identified a muscle niche-driven Insulin-Notch-dMyc regulatory cascade ([Figure 8](#fig8){ref-type="fig"}) that governs AMP entry into proliferation.

Homing behavior of AMPs to their muscle niche {#s3-1}
---------------------------------------------

It is widely accepted that stem cells reside in a specific microenvironment, the niche, defined as an interactive structural unit organized to facilitate cell-fate decisions in a proper spatiotemporal manner ([@bib35]). The niche of satellite cells located underneath the basal lamina of myofibers is composed of cellular and extracellular components (muscle fiber and basal lamina) that are sufficient for satellite cell activation, proliferation and differentiation ([@bib57]). Niche properties, particularly of its muscle component, also appear crucial for the regenerative potential of satellite cells during aging ([@bib11]) and satellite cell engraftment in cell therapy approaches ([@bib5]).

The stem-like *Drosophila* AMPs specified in mid-embryogenesis lie at the origin of all the adult *Drosophila* muscles ([@bib3]), but the lack of appropriate genetic tools means we still know little of their behavior and niche requirements. Here, we monitored the morphology of embryonic AMPs using a m6-gapGFP sensor line and found that in addition to the long cytoplasmic extensions that connect AMPs together ([@bib16]), they also send out numerous thin filopodia and display homing behavior to a set of surrounding muscles. The newly specified AMPs initially display spherical shapes with short thin filopodia distributed around their surface, but shortly afterwards they start to send filopodia in a more directional way, become more elongated extending along the neighboring muscles and connecting them via stabilized cellular protrusions. Thus, the dormant AMPs, like vertebrate satellite cells, adapt their shapes to muscle niche and became tightly associated with muscle fibers, an assumption supported by dotty integrin expression associated with both AMP cell bodies and their muscle-connecting filopodia. Interestingly, the quiescent satellite cells also have the capacity to produce cellular extensions, called nanotubes, connecting muscle stem cells to the muscle fiber ([@bib51]), which further argues that AMPs and satellite cells display similar behavior. How the homing of satellite cells and AMPs is regulated remains to be explored, but the Notch pathway, which is activated in AMPs and required to produce basal lamina by adhering to muscle satellite cells ([@bib9]), appears to play a central role. It is also unknown how satellite cells behave during their reactivation, how they adapt their shapes, and when they lose nanotube connections to muscle niche. Using membrane-targeted GFP enabled us to follow the behavior of AMPs and, for the first time, to visualize them at the time they are reactivated from the dormant state. Our data reveal that the AMPs maintain their elongated shapes with filopodia extending along the muscle niche during the first events of proliferation, which supports the view that muscles play an instructive role during AMP reactivation.

Insulin-Notch-dMyc cascade controls AMP reactivation and proliferation {#s3-2}
----------------------------------------------------------------------

AMPs are reactivated from their quiescent state at the mid-second larval instar, but the signals and intrinsic molecular mechanisms regulating their entry into proliferation remain unknown. It has previously been shown that the Insulin/TOR signaling pathway controls the exit of *Drosophila* neural stem cells from their dormant state ([@bib12]; [@bib50]). Global gene expression profiling also revealed that Insulin Growth Factor (IGF) signaling components are upregulated in activated satellite cells ([@bib40]). We therefore tested whether the Insulin pathway could reactivate *Drosophila* AMPs. We found that Insulin and TOR signaling components effectively promote the exit of AMPs from their dormant state, while also positively regulating AMP proliferation. However, increased Insulin/TOR signaling alone is not sufficient to end AMP quiescence during embryonic stages, suggesting a more complex regulatory cascade for the control of AMP reactivation. It has been demonstrated that the reactivation of dormant neuroblasts is driven by a nutritional checkpoint during the second larval instar ([@bib12]; [@bib50]). Given that AMPs also remain quiescent in nutrient deprivation settings, we hypothesize that a nutrient-dependent switch in metabolism may contribute to AMP reactivation, and might thus be responsible for the inability of embryonic AMPs to enter proliferation. Quiescent stem cells have few mitochondria and use anaerobic metabolism, whereas activated cells switch their metabolism to a high ATP energy output aerobic glycolysis in order to support the high-level macromolecular synthesis required for proliferation, ([@bib34]). Interestingly, genes encoding glycolytic and pyruvate metabolic enzymes known to be downstream of Insulin ([@bib52]) act as upstream regulators of the Notch pathway ([@bib47]), providing a potential link between metabolism and Notch in regulating the quiescent versus activated state of stem cells. A well-known feature of quiescent non-differentiated cells is that they keep Notch activated ([@bib4]), but Notch receptor activation can also trigger proliferation ([@bib1]), including the proliferation of satellite cells ([@bib43]). Here, we followed the GFP expression driven by a Notch-responsive element of the *m6* gene and found that dormant AMPs are GFP-positive, which suggests that, like in satellite cells, Notch is involved in setting the AMP quiescent state. On the other hand, we also observed that during larval stages Notch promotes AMP proliferation, indicating that Notch might play a dual role, again like in satellite cells ([@bib43]). Notch acting in concert with Numb is also known to control asymmetric divisions of adult satellite cells ([@bib27]). However, in *Drosophila*, Numb has no impact on AMP proliferation, indicating a novel role for Notch in promoting symmetric cell divisions of AMPs. As Notch regulates the proliferation of cancer cells via Myc ([@bib41]; [@bib55]; [@bib29]; [@bib24]), and Myc promotes the proliferation of myoblasts during development and regeneration ([@bib28]), we tested whether dMyc was involved in AMP reactivation in *Drosophila*. Our data show that dMyc is indeed required for AMP reactivation and proliferation. Genetic rescue experiments show that Notch acts downstream of the Insulin pathway and dMyc functions downstream of Notch. Interestingly, it has been shown that coordinated activation of Insulin and Notch pathways also regulates the self-renewal and differentiation of intestinal *Drosophila* stem cells ([@bib17]). Here, our data suggest that Notch pathway activation downstream of Insulin involves Deltex and is likely ligand-independent ([Figure 7](#fig7){ref-type="fig"}). The role of ligand-independent Notch activation, which involves interaction with Hif-α, has been reported as essential for normal *Drosophila* blood cell development ([@bib37]). Our findings further highlight the biological importance of non-canonical Notch activation and provide early evidence for its role during stem cell-niche interactions.

Muscle niche reactivates AMPs via dIlp6 {#s3-3}
---------------------------------------

The key role of the Insulin pathway in AMP proliferation raised an obvious question as to the source and identity of the Insulin Receptor (InR) ligand initiating AMP reactivation. In *Drosophila*, three Insulin-like peptides (dIlp2, dIlp3 and dIlp5) secreted to the hemolymph by mNSC cells control the systemic growth of the organism ([@bib8]), whereas dIlp6 produced by the glial cells acts locally and promotes the proliferation of the neuroblasts ([@bib50]).

Here we show that dIlp6 is also crucial for reactivating AMPs from their dormant state. On the other hand, the lack of substantial effect on AMP proliferation observed in *dIlp2, dIlp3* and *dIlp5* mutants suggests that dIlps secreted to the hemolymph are unable to reactivate AMPs and that direct contact between AMPs and surrounding muscles via long cellular protrusions promotes the reception of local, muscle-derived dIlp6 by the closely-associated AMPs.

Thus, like for satellite cells ([@bib11]), muscle appears to play a niche role while also proving essential to the activation of quiescent AMPs ([Figure 8](#fig8){ref-type="fig"}). Whether the Insulin/IGF signals play a conserved role in this process remains an open question, but the finding that numerous IGF signaling components are upregulated in activated satellite cells ([@bib40]) argues for this possibility.

Taken together, our data reveal several new features of the transient *Drosophila* muscle stem cells called AMPs, particularly their direct contact with muscles, which behave as an AMPs niche. Muscle appears to be the source of local inductive Insulin signals that reactivate AMPs and, via non-canonical Notch and its target dMyc, induce their proliferation in larval stages ([Figure 8](#fig8){ref-type="fig"}). If all the components of this cascade prove to be evolutionarily conserved, it is tempting to speculate that this same cascade may also control the reactivation of human satellite cells.

Material and methods {#s4}
====================

Fly stocks {#s4-1}
----------

All *Drosophila melanogaster* stocks were grown on standard medium at 25°C. The overexpression experiments were performed by UAS-GAL4 system ([@bib6]). *w^1118^* was used as a wild type. The following strains were used: *UAS-PTEN, UAS-TSC1, TSC2* ([@bib42]* UAS-dMyc* ([@bib39]) (gift from F. Demontis, Judes Children Hospital, USA), *Tubulin-PH-GFP (tPGH*) (gift from B. Edgar, University of Heidelberg, Germany), Duf-GAL4 (gift from K. Vijayraghavan, NCBS, India), *UAS-NotchDN, UAS-NICD, UAS-Deltex UAS-Kurtz, UAS-Su (Dx)* (gift from Spyros Artavanis-Tsakonas, Harvard Medical School, USA), *UAS-Shrub* (a gift from Fen Biao-Gao, University of Massachusetts Medical School, USA), *UAS-ShrubRNAi* (gift from Janice A. Fischer, Texas University, USA),

*Mef-Gal4, UAS-Krz, UAS-LacZ, UAS-InRCA, UAS-RHEB, UAS-mCD8Cherry, UAS-ShibireDN, UAS-rpr, Elav-GAL4, Repo-GAL4* and the mutant stocks for *Df (Ilp6), Df (Ilp2), Df (Ilp5)* were obtained from the Bloomington stock center (BL27390, BL27889, BL1776, BL8250, BL9689, BL27391, BL5811, BL5824, BL458, BL7415, BL30885, BL30881, BL30884, respectively). *UAS-KurtzRNAi, UAS-DeltaRNAi, UAS-SerrateRNAi, UAS-DeltexRNAi, UAS-Su (Dx)RNAi, UAS-dMycRNAi, UAS-NotchRNAi, UAS-Ilp6RNAi, UAS-shrubRNAi, UAS-DAAMRNAi* (V103756, V37287, V27174, V7795, V103814, V106066, V10002, V102465, V106823, V24885, respectively) came from Vienna Drosophila Research Centre (VDRC). Double transgenic lines *UAS-InRCA;UAS-NotchRNAi, UAS-InRCA;UAS-dMycRNAi, UAS-InRCA;UAS-LacZ, UAS-NICD;UAS-dMycRNAi, UAS-InRCA;UAS-Krz, UAS-InRCA;UAS-Dx, m6-Gal4;UAS-Krz, m6-Gal4;UAS-Dx and UAS-PTEN;UAS-Dx* were generated by standard genetic crosses. Crosses and embryo collection were performed at 25°C.

Generation of m6-gapGFP and sensor-driver stocks {#s4-2}
------------------------------------------------

To generate m6-gapGFP, the eGFP coding sequence from the pGreen Pelican vector ([@bib2]) was replaced by the gapGFP coding sequence (a fusion of the myristylization sequence from *GAP43* gene to GFP, designed to target the GFP to cell membrane) from the pCA-gapGFP vector (gift from A. Chiba, University of Miami, USA). The regulatory sequences from the upstream region of the *m6* gene, with expression seen in AMPs ([@bib16]), were PCR-amplified from the genomic DNA and inserted into the multiple cloning site (MCS) region. Germline transformation of the m6-gapGFP vector and the generation of transgenic lines were performed by the Fly-Facility platform (www.fly-facility.com) using the standard P-element-based transgenesis method. Sensor-driver stocks consisting of m6-gapGFP and m6-GAL4 (targeting AMPs) or Elav-GAL4 (targeting neural cells) were generated by standard genetic crosses.

Histology, AMP cell counting and statistical analyses {#s4-3}
-----------------------------------------------------

Embryos from the synchronized cages were collected within 2 h. L1 larvae collected within 2 h of hatching were grown on standard medium at 25°C. At 96 h AEL period, mid-third instar larvae were pinned flat and dissected in calcium-free PBS. Larvae staging was supported by the mouth hook morphology. The internal organs were removed to expose the body-wall muscles, and fixed in 4% formaldehyde for 20 min. After fixation, the dissected larvae were washed twice in PBS and used for immunostaining via standard procedures. AMPs were visualized by staining with Twist antibody, and the number of AMPs per group was counted in the A2--A5 abdominal segments. All samples were co-stained with phalloidin, and only larvae with intact muscles were selected for AMP counting and quantification.

Flat preparations of the first and second instar larvae were prepared according to [@bib31], and used for the immunostaining as stated above.

For each genotype, at least eight larvae were dissected and the ventral, lateral and dorsal AMP groups were used for counting (sample sizes for each genotype are indicated in [Figure 4---source data 1](#SD1-data){ref-type="supplementary-material"}, [Figure 5---source data 1](#SD2-data){ref-type="supplementary-material"}, [Figure 6---source data 1](#SD3-data){ref-type="supplementary-material"} and [Figure 7---source data 1](#SD4-data){ref-type="supplementary-material"}). For each experiment, we calculated a mean value that was used to generate the graphs. The standard error of the mean (SEM) was applied to calculate the error bars. A student's t-test and Prism software were used to calculate the *P*-values.

Growing the larvae in nutrient-restricted conditions {#s4-4}
----------------------------------------------------

Embryos from the synchronized cages were collected 2 hr after laying and allowed to develop on plates with sugar-agar medium (5% sucrose, 1% agar) at 25°C. L1 larvae were collected and allowed to grow on fresh sugar-agar plates at 25°C. At 96 h AEL, the larvae were pinned flat and dissected in calcium free PBS. The internal organs were removed to expose the body-wall muscles, and mounted on a coverslip to visualize AMPs under the confocal microscope.

Genetic epistasis experiments {#s4-5}
-----------------------------

Genetic epistasis experiments were performed to determine interactions between Insulin and Notch pathways and between Notch and dMyc during AMP reactivation. We first generated double UAS-InRCA; UAS-NotchRNAi, UAS-Notch-Intra; UAS-MycRNAi, UAS-InRCA; UAS-Deltex, UAS-PTEN; UAS-Deltex, UAS-InRCA; UAS-Kurtz; UAS-Deltex; UAS-Kurtz and UAS-InRCA; UAS-lacZ transgenic lines. Each of these double transgenics was then crossed with the m6-GAL4 driver. The derived synchronized mid-stage third instar larvae were dissected and immunostained to reveal muscles and AMPs. AMPs were counted and their numbers compared against m6\>InRCA and m6\>Notch-Intra contexts.

Antibody staining and imaging {#s4-6}
-----------------------------

Fluorescent staining was performed using the following antibodies: rabbit anti-Twi ([@bib16]) (1:300), rabbit anti-dMyc (1:300) (Santa-Cruz Biotechnology), goat anti-GFP (1:1000) (Biogenesis), rabbit anti-PH3 (1:1000) (Millipore), mouse anti-NICD (1:150), rat anti-Deltex (1:50) (kindly provided by S. Artavanis-Tsakonas, Harvard Medical School, USA), mouse anti-Lamin (1:1000) (DHSB LC28.26), rat anti-Tropomyosin (1--200; Babraham Bioscience Technologies, UK; BT-GB-141), mouse anti-αPS1 (1:50; DHSB; DK.1A4), mouse anti-βPS (DSHB CF.6G11), Phalloidin-TRITC (1:1000) (Sigma). Cy3, Cy5 and Alexa 488-conjugated secondary antibodies (Jackson ImmunoResearch) were used (1:300). Embryos were mounted in Fluoromount-G anti-fade reagent (Southern Biotech). Labeled embryos were analyzed using Leica SP5 and SP8 confocal microscopes. 3D reconstructions of the images were generated using Imaris software (Bitplane).

Signal intensity measurements and statistical analyses {#s4-7}
------------------------------------------------------

All confocal images used to measure signal intensity were acquired at the same microscope settings. Equal numbers of stacks per image were taken for the different genetic contexts, and mean fluorescent intensity of a single cluster of AMPs from the abdominal segments of the mid-third instar larvae was measured using ImageJ software. For each genotype, 4-6 larvae were dissected and 12--15 segments were analysed. Mean fluorescence intensity for a given cluster of AMPs was determined by averaging the signal intensities measured in three representative AMP cells from that cluster. Statistical analyses were performed by a Student's *t*-test using Prism software and Microsoft Excel.
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for submitting your work entitled \"Muscle niche-driven Insulin-Notch-Myc cascade reactivates dormant Adult Muscle Precursors in *Drosophila*\" for peer review at *eLife*. Your submission has been favorably evaluated by K VijayRaghavan (Senior Editor), a Reviewing Editor, and three reviewers.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

The reviewers appreciate this original study of the communication between *Drosophila* Adult Muscle Precursors (AMPs) and their *niche*, providing interesting parallels with the niche of satellite cells in adult vertebrates. The authors report observations on filopodia produced by AMPs to contact the muscle and investigate signaling pathways that control AMP behaviour, with novel findings on ligand independent activation of Notch by upstream action of the insulin receptor, which in turn is controlled by dIlp6 produced by the muscle.

The following points need to be addressed:

1\) Niche \'homing\' behavior of the AMPs is the least well-supported part of the manuscript and relies largely on description of AMP position and morphology. Are the preferences for filipodial contact between AMPs and specific muscle fibers relevant, or merely due to proximity? This is easily tested using ablation of specific fibers or genetic backgrounds in which they fail to form (the Keshishian lab did this to great effect for studies of motorneuron innervation in the mid-1990s, for example). Such studies would bolster the idea that the cells home to the niche and may reveal some interesting insights.

The second and third paragraphs of the subsection "AMPs display homing behavior and became tightly associated with neighboring muscles" ("Embryonic AMPs are the immediate neighbors of somatic muscles \[...\] tightly associated"; "Interestingly, filopodial AMP-muscle connections appear to follow a stereotyped pattern \[...\] are decorated by punctate integrin's expression") need to be rephrased, as the description is not clear. Because filopodial extensions are generally viewed as highly dynamic, the characterization of AMP filopodia should include: range, dynamics (stability); target specificity; position of integrin accumulation. This is important to support the conclusion that \"direct contacts between AMPs and surrounding muscles favor reception of local muscle-derived dIlp6\" (paragraph two, subheading "Muscle niche reactivates AMPs via dIlp6"). If technically possible, an improved 3-D view (reconstruction?) of AMP/Muscle contacts via filopodia would help non-expert readers to appreciate the positioning of AMPS relative to internal, median and external muscle *layers*. What happens to signaling if filipodia are disrupted?

In conclusion, the authors do little to investigate the relevance of the filipodia in either homing or signaling. A detailed analysis is probably beyond the scope of this article but some attempt to clarify ideas about their function should be made, along the lines indicated above.

2\) A second point concerns the Gal4 drivers used.

The authors' statement that muscles are the source of Dilp6 acting on AMPs, is based on using a pan-mesodermal Mef2 driver ([Figure 6 G-I](#fig6){ref-type="fig"}). This driver could also affect the AMPS. An additional specific muscle driver e.g. MHC-Gal4 should be used. Furthermore, since drivers exist that are only active in subsets of somatic muscles, some contacted by AMPs, others not, use of these would be informative as to whether direct contacts between specific muscles and AMPs are instructive.

vM6-Gal4 is generated from a Notch dependent enhancer. This complicates the experiments when Notch is manipulated. For example, inhibition of Notch would reduce expression of M6-Gal4. This can in turn impact on expression of the other RNAi\'s and modify the phenotypes. At least some experiments should be repeated with an independent Gal4 to verify the effects.

3\) The authors argue that the effects of Notch involve ligand-independent signaling, but they have not really tested that. Dx and Su(Dx) can also affect ligand dependent signaling. A strategy that blocks ligand dependent signaling would clarify this issue e.g. by blocking the ADAM protease.

The conclusion that N acts downstream of InR in stimulating AMP proliferation is novel and of potential strong impact in the field. Yet, the authors should leave open the possibility that N acts also independent of InR since overexpressing NICD induces higher number of AMPs ([Figure 3J](#fig3){ref-type="fig"} and [Figure 4L](#fig4){ref-type="fig"}) than InRCA, although not higher Myc levels ([Figure 4J](#fig4){ref-type="fig"}).

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Muscle niche-driven Insulin-Notch-Myc cascade reactivates dormant Adult Muscle Precursors in *Drosophila*\" for further consideration at *eLife*. Your revised article has been favorably evaluated by K VijayRaghavan (Senior Editor), a Reviewing Editor, and three reviewers. The manuscript has been greatly improved and the new [Video 4](#media4){ref-type="other"} was appreciated, but there are some remaining modifications that need to be made to the manuscript before acceptance, as outlined below:

1\) On the one hand, the authors use the expression from the m6 enhancer (m6-GFP) expression to argue that Notch is active in the AMPs, but then they now argue that the expression from the same enhancer (in m6-Gal4) can\'t be reduced when Notch activity is attenuated. These claims are rather contradictory. Most likely there is a simple explanation (perdurance of Gal4 and GFP in the latter?) but this does make the results confusing for the reader (e.g. subheading "Notch acts downstream of the Insulin pathway and regulates the proliferation of AMPs via dMyc" and in the Discussion: \"Here we followed the GFP expression driven by a Notch-responsive element of the *m6* gene and found that the Notch pathway was active in dormant AMPs\"). Can they be confident that this is reading out Notch activity at that time? Maybe the enhancer requires Notch for activation but not for maintenance? Given the data they have provided, I suggest that they tone down their statements.

2\) Teasing apart the ligand dependent versus ligand independent Notch activity is tricky. The authors discuss in the rebuttal their experiment with the KuzDN, which gives minor effects that they argue should be ignored. But at the same time they place quite a strong emphasis on the role of Deltex despite the fact that the results in this section are confusing and contradictory (e.g. over-expressing and attenuating Deltex have the same effects, likewise Su(dx), likewise kurtz). Given these contrary data, it doesn\'t seem appropriate to make major conclusions about the roles of these factors so I suggest that they remove the scheme from the right hand part of [Figure 8](#fig8){ref-type="fig"} and further moderate their statements about the role of Dx. Altering Deltex activity does influence the AMPS but it is not clear that it is the main effector of the signaling through InR nor the critical regulator of Notch in this context.

3\) [Figure 6--figure supplement 1A](#fig6s1){ref-type="fig"} presents a hypothetical scheme not directly connected to experiments described in the manuscript. It should be removed.
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Author response

*The following points need to be addressed:*

1\) Niche \'homing\' behavior of the AMPs is the least well-supported part of the manuscript and relies largely on description of AMP position and morphology. Are the preferences for filipodial contact between AMPs and specific muscle fibers relevant, or merely due to proximity? This is easily tested using ablation of specific fibers or genetic backgrounds in which they fail to form (the Keshishian lab did this to great effect for studies of motorneuron innervation in the mid-1990s, for example). Such studies would bolster the idea that the cells home to the niche and may reveal some interesting insights.

The AMPs interact with immediately neighboring muscles but seem to have some preferences in interactions so that for example the most anterior lateral AMP interacts preferentially with LT and LO1 lateral muscles whereas posterior lateral AMP is mainly connected to the SBM. As suggested in comment 1 we performed a series of targeted muscle ablations to test AMPs behavior in the context neighboring muscles are absent. To do so we expressed inducer of apoptosis Reaper specifically in muscle founder cells using Duf-Gal4 driver (we favor genetic ablation method over laser ablation). This has led to a range of muscle ablation phenotypes (new [Figure 2 B-D](#fig2){ref-type="fig"}) and the following observations:

1\) In segments with partial loss of LT/LO1 muscles the anterior lateral AMP, which normally extends anteriorly to interact with LO1, LT3/2/1 (white arrow in [Figure 2A](#fig2){ref-type="fig"}) remained tightly associated with posterior lateral AMP and interacted mainly with SBM muscle (white arrows in [Figure 2 B and C](#fig2){ref-type="fig"}).

2\) In segments with loss of dorsal and dorso-lateral muscles and with some LT muscles persisting ([Figure 2B](#fig2){ref-type="fig"}) the dorso-lateral AMPs interacted with remaining LT1/2 muscles (arrowhead in [Figure 2B](#fig2){ref-type="fig"}) to which they do not connect in the wild type context (arrowhead in [Figure 2A](#fig2){ref-type="fig"}) indicating some plasticity in AMPs connections.

3\) In segments with a pronounced loss of dorsolateral and lateral muscles ([Figures 2B and C](#fig2){ref-type="fig"}) the dorsal and dorso-lateral AMPs adopted rounded shapes (yellow arrows) and were unable to migrate to other segments or to the ventral region in which muscles were still present.

4\) In embryos with a total muscle ablation the majority of remaining AMPs adopted rounded shapes (yellow arrows in [Figure 2D](#fig2){ref-type="fig"}). The number of AMPs detected was drastically reduced (asterisks indicate lacking AMPs) suggesting that in the absence of muscles AMPs do not survive.

All these observations indicate that there is a plasticity of AMP interactions with neighboring muscles. However, there is also dorsal-ventral positional information restricting these interactions in a way dorsal AMPs are unable to migrate and interact with lateral muscles when dorsal muscles are ablated.

Also AMPs association with muscle niche appears crucial for their survival as AMPs number is drastically reduced when muscles are absent (see progressively increasing number of lacking AMPs, indicated by asterisks, correlating with the severity of muscle loss phenotypes -- compare [Figures 2B, C and D](#fig2){ref-type="fig"}).

After analyzing a range of muscle ablation phenotypes generated in Duf\>Rpr context we assume that we already generated ablations similar to those that could be generated by drivers targeting subsets of muscles.

We also used anti-Elav staining to test whether in Duf\>Rpr context the PNS is not affected (data not shown). We didn't find any defects in the PNS.

*The second and third paragraphs of the subsection "AMPs display homing behavior and became tightly associated with neighboring muscles" ("Embryonic AMPs are the immediate neighbors of somatic muscles \[...\] tightly associated"; "Interestingly, filopodial AMP-muscle connections appear to follow a stereotyped pattern \[...\] are decorated by punctate integrin's expression") need to be rephrased, as the description is not clear. Because filopodial extensions are generally viewed as highly dynamic, the characterization of AMP filopodia should include: range, dynamics (stability); target specificity; position of integrin accumulation. This is important to support the conclusion that \"direct contacts between AMPs and surrounding muscles favor reception of local muscle-derived dIlp6\" (paragraph two, subheading "Muscle niche reactivates AMPs via dIlp6"). If technically possible, an improved 3-D view (reconstruction?) of AMP/Muscle contacts via filopodia would help non-expert readers to appreciate the positioning of AMPS relative to internal, median and external muscle* layers*. What happens to signaling if filipodia are disrupted? In conclusion, the authors do little to investigate the relevance of the filipodia in either homing or signaling. A detailed analysis is probably beyond the scope of this article but some attempt to clarify ideas about their function should be made, along the lines indicated above.*

Indeed a detailed analysis of homing appears beyond the scope of this article. However, to provide some insights into raised issues we performed series of experiments and provide now a more detailed view of AMPs localization, interaction with surrounding muscles and filopodia dynamics.

To better characterize AMPs localization with respect to internal, intermediate and external muscles (now schematized in revised [Figure 1D'-G'](#fig1){ref-type="fig"}), we created Z-stack movies of stage 14 and stage 15 M6-gapGFP embryos ([Video 2](#media2){ref-type="other"} and [Video 3](#media3){ref-type="other"}) stained for muscles and AMPs. We incorporated slice annotations to indicate position of AMPs with respect to muscle layers.

These movies clearly show that AMPs are not associated with one particular muscle layer. Also the ventral, lateral, dorso-lateral and dorsal AMPs have distinct internal/external locations. The lateral AMPs extend from the external to internal layer. The posterior lateral AMP (arrowhead in Z-stack movies) lies the most externally and is seen at the same optical level that the external lateral muscles (ExtLM: LT muscles). The anterior lateral AMP (arrow in Z-stack movies) lies more internally, mainly at the level of internal lateral muscles (IntLM: LO1 and SBM). The ventral AMPs are located in between external ventral muscles (ExtVM: VA1 and VA2) and intermediary ventral muscles (ImVM: VO3-VO6) but they send cellular extensions externally and are seen at the level of VA1 and VA2.

The dorso-lateral AMPs are clearly located under the external DT1 and lies mainly in between the intermediary dorsal muscles (InDM: DO3 and DO4) and internal dorsal muscles (IntDM: DA3). Finally, the dAMPs are located in between the external (ExtDM: DO1 and DO2) and internal dorsal muscles (IntDM: DA1, DA2).

Note: Please view movies ([Video 2](#media2){ref-type="other"} and [Video 3](#media3){ref-type="other"}) frame by frame to appreciate AMPs positioning and to see corresponding annotations. Corresponding comments are included in the Results section.

We also made additional αPS1 integrin staining at three different developmental time points to better document integrin distribution associated with the filopodia and with the AMP cell bodies. This is presented as Z-stack projections of lateral AMPs at three different time points (new [Figure 2 E-G](#fig2){ref-type="fig"}') and Z-stack 2 and 3 channels movies showing punctate decoration of lateral AMPs by αPS1 integrin at stage 16 (Figure 2--figure supplement 1A and 1B). We observed that the first αPS1 dotty signals associated with AMPs appear at late stage 14 (new [Figure 2E, E](#fig2){ref-type="fig"}') and are progressively enriched at stage 15 and 16 (new [Figure 2F-G](#fig2){ref-type="fig"}'). We observe punctate αPS1 pattern associated mainly with AMP cell bodies but also aligned with filopodia (clearly seen at stage 16, arrows in new [Figure 2G, G](#fig2){ref-type="fig"}').

Similar but more discrete βPS pattern is also observed (new [Figure 2H, H](#fig2){ref-type="fig"}'). The AMP cell bodies and filopodia-associated αPS1 dots are also shown in Z stack movies ([Videos 5](#media5){ref-type="other"} and [6](#media6){ref-type="other"}) -- view 2 and 3 channels movies in parallel frame by frame to follow αPS1 dots associated with the AMPs and corresponding annotations. As filopodia are highly dynamic structures we hypothesize that the filopodia-associated αPS1 dots mark cellular extensions that are getting in contact with target muscles and are in the process of stabilization. This possibility is supported by the observation that a subset of filopodia get indeed stabilized (arrowheads in [Video 4](#media4){ref-type="other"}).

Corresponding comments were included to the revised text, in the Results section.

To characterize filopodia dynamics we performed lifetime imaging of M6-gapGFP labeled AMPs at embryonic stage 15 ([Video 4](#media4){ref-type="other"}). The chosen developmental time window corresponds to the homing period in which AMPs actively send filopodia and try to contact target muscles. Z stacks were taken each 1 min during the period of 35 minutes. Leica SP8 confocal microscope with fast resonant scanner was used for live imaging. ImageJ was used to register and to annotate the movie.

We focused on and annotated the lateral AMPs. To follow the number of filopodia and the direction of their projection we labeled the extremities of all filopodia at each time point (indicated by yellow open circles, [Video 4](#media4){ref-type="other"}). This revealed that the lateral AMPs send filopodia non-randomly and mainly in anterior-dorsal directions, which correlate with location of SBM and LO/LT muscles to which lateral AMPs are connected by stage 16. We observe that between 6 and 9 filopodia are produced at each time point over the lifetime experiment. Interestingly, some of filopodia/cellular extensions are more stable than others (indicated by arrowheads). The anterior lateral AMP extension that appears stabilized and persists until the end of movie (arrowhead) ensures connection to LO1 and LT muscles. Filopodia projecting in dorsal direction (denoted by the arrowhead) potentially connecting the SBM persists few minutes but does not acquire stable state.

Note: A frame by frame viewing of the movie will allow to count number of filopodia per time point and appreciate filopodia extension and retraction events.

We included the corresponding comments in the Results section.

As suggested by the reviewers, we also attempted to affect filopodia and to test whether they play a role in signal transduction from muscles to the AMPs. To interfere with filopodia formation we tested several genetic contexts including overexpression of dominant negative form of CDC42 (CDC42DN) or Rac1 (Rac1DN), attenuation of Diaphanous (Diaphanous RNAi) and attenuation of DAAM (DAAM RNAi) (data not shown). Among them we found that AMP-targeted attenuation of DAAM encoding one of the formins produces the most penetrant phenotypes. In DAAM RNAi context we observed that AMP filopodia length is significantly reduced in 2^nd^ instar larvae (new [Figure 7L](#fig7){ref-type="fig"}) and AMP cell number decreased when counted in mid-3^rd^ instar (new [Figure 7M](#fig7){ref-type="fig"}) thus suggesting affected AMPs reactivation.

These data support a view that filopodia play an important role in AMPs reactivation.

2\) A second point concerns the Gal4 drivers used. The authors' statement that muscles are the source of Dilp6 acting on AMPs, is based on using a pan-mesodermal Mef2 driver ([Figure 6 G-I](#fig6){ref-type="fig"}). This driver could also affect the AMPS. An additional specific muscle driver e.g. MHC-Gal4 should be used. Furthermore, since drivers exist that are only active in subsets of somatic muscles, some contacted by AMPs, others not, use of these would be informative as to whether direct contacts between specific muscles and AMPs are instructive.

We previously documented (Jagla et al., Development 1998, 125, 3699-708) that *Mef2* gene expression is excluded from the Twist-expressing AMPs and used here Mef-Gal4 driver based on this observation. In response to the reviewers' comment, we however tested Mef-Gal4 expression by crossing it to UAS-GFP. We observed that, like *Mef2* gene, the Mef-GAL4 driver is strongly expressed in somatic muscles of second instar larvae but is not active in AMPs (documentation of Mef-GAL4 expression not shown). Thus we are confident that data presented in [Figure 7](#fig7){ref-type="fig"} are resulting from somatic muscle activity of Mef-Gal4.

Regarding drivers expressed in subsets of muscles such as Lb-Gal4 or Slou-Gal4 (we currently use in the lab for targeting individual muscles), they drive expression at relatively high levels in embryos but their activity drops down in larval stages and are thus not well adapted for studying muscle derived signals in larval stages. Moreover, the Slou-Gal4 drives also expression in ventral AMPs and Lb-Gal4 in lateral AMPs.

*vM6-Gal4 is generated from a Notch dependent enhancer. This complicates the experiments when Notch is manipulated. For example, inhibition of Notch would reduce expression of M6-Gal4. This can in turn impact on expression of the other RNAi\'s and modify the phenotypes. At least some experiments should be repeated with an independent Gal4 to verify the effects.*

M6-Gal4 driver has been generated using previously described (Lai et al., Development 2000, 127, 3441-55) 2.1 kb m6 regulatory element covering -2098 to +37 of m6 and carrying 4 putative Su(H) binding sites. This element has been previously shown to drive expression of GFP specifically in embryonic and larval AMPs (Lai et al., Development 2000, 127, 3441-55). We agree with the reviewers that M6-Gal4 is not a perfect tool for manipulating Notch, however we observed that it keeps active in the context Notch is attenuated indicating that Notch is not the only regulator of its activity and/or that a low level of Notch is sufficient to maintain M6-Gal4 active.

The following observations are in support of this view:

1\) After crossing M6-Gal4 with UAS-NotchRNAi line we observed a strong decrease of AMP proliferation ([Figure 4G, J](#fig4){ref-type="fig"}) indicating that Notch was attenuated and suggesting that M6 regulatory sequences are robust enough to keep active in the context of reduced Notch.

2\) We tested activity of m6 regulatory element by imaging M6-gapGFP (GFP driven by the same 2.1 kb element) in wt AMPs (lacZ context) and in AMPs with reduced Notch (Notch RNAi context). Representative images showing anterior cluster of lateral AMPs acquired with the same confocal settings with a graph of fluorescence intensity are shown in [Figure 4--figure supplement 2](#fig4s2){ref-type="fig"}. This comparison reveals that attenuation of Notch does not lead to the loss of 2.1 kb m6 element activity. Measuring of fluorescence intensity reveals mean value reduction of about 10%.

Thus we are confident that the attenuation of Notch has no major effect on M6 driver activity.

Regarding alternative AMP drivers, to our knowledge, the only one reported so far is the 1151-Gal4 (Roy and VijayRaghavan, Development 1997, 124, 3333-41; Anant et al., Development 1998, 125, 1361-9). It is expressed in AMPs associated to 3^rd^ instar wing and leg imaginal discs and it has also been reported (Sudarsan et al., Dev Cell 2001, 1, 829-39) that 1151-Gal4 is expressed from 1^st^ instar in AMPs and in the fat body. Thus, 1151-Gal4 appears activated later than M6-Gal4 and its expression is not restricted to AMPs.

On the other hand, 1151-Gal4 is an enhancer trap insertion, mapped to cut locus encoding a homeodomain transcription factor regulated by Notch (Sun and Deng, Development 2005, 132, 4299-308). It is thus difficult to exclude Notch influence on 1151-Gal4, which seems not to be a good alternative for driving expression specifically in AMPs and in a Notch independent way.*3) The authors argue that the effects of Notch involve ligand-independent signaling, but they have not really tested that. Dx and Su(Dx) can also affect ligand dependent signaling. A strategy that blocks ligand dependent signaling would clarify this issue e.g. by blocking the ADAM protease.*

We agree with the reviewers that we did not test all players in ligand-independent Notch activation and that Deltex can also affect ligand dependent signaling. In consequence we modified our statements in the text from "ligand independent Notch signaling" to "Deltex-involving Notch signaling".

Regarding Deltex, we revise our statement in the text ("To further explore the link between Insulin and Notch pathway we tested expression of the ubiquitin ligase Deltex, known to be involved in ligand-independent intracellular activation of Notch by promoting its mono-ubiquitinated state (Hori et al., J Cell Biol 2011, 195, 1005-15)").

Regarding, blocking ligand dependent Notch signaling, we already did it using a dominant negative allele of Notch called ECN and consisting of extracellular and transmembrane domains but lacking all the intracellular Notch sequence (Rebay et al., Cell 1993, 74, 319-29; Klein et al., Dev Biol 1997, 189, 123-34; please see revised version [Figure 6--figure supplement 1](#fig6s1){ref-type="fig"}). Overexpression of ECN was previously found to mimic loss of function phenotypes of Notch (Rebay et al., Cell 1993, 74, 319-29) and it was then used in more than 50 publications for mimicking/testing loss of canonical Notch signaling. We found that overexpression of ECN in AMPs has no effect on their reactivation supporting ligand-independent Notch activation. A notion that is also consistent with the increased number of AMPs after attenuation of Shrub ([Figure 6F](#fig6){ref-type="fig"}).

Regarding blocking Kuzbanian/Adam10 protease we followed the reviewers' suggestion and overexpressed a dominant negative form of Kuzbanian (stock BL6578) in AMPs. We found that blocking Kuzbanian function has a minor influence on AMPs number (about 15% less of lateral AMPs counted in 30 segments compared to control). This supports the view that Kuzbanian-involving ligand dependent Notch signaling has no major role in AMPs reactivation.

However, whether Kuzbanian acts exclusively in ligand-dependent way remains unclear. To our knowledge the ligand independent Notch activation also involves series of cleavages and in particular the gamma-secretase-involving cleavage of Notch-derived NEXT-like substrate, normally generated upon S2 cleavage by Kuzbanian (Schneider et al., J Cell Sci 2013, 126, 645-56). Thus, with no clear view on Kuzbanian function in ligand-independent versus-ligand dependent Notch signaling we thought including AMP count data from M6\>KuzDN context (data not shown) would not reinforce the already presented data.

The conclusion that N acts downstream of InR in stimulating AMP proliferation is novel and of potential strong impact in the field. Yet, the authors should leave open the possibility that N acts also independent of InR since overexpressing NICD induces higher number of AMPs ([Figure 3J](#fig3){ref-type="fig"} and [Figure 4L](#fig4){ref-type="fig"}) than InRCA, although not higher Myc levels ([Figure 4J](#fig4){ref-type="fig"}).

We agree with this comment and added the following statement: "However, because overexpressing of NICD induces higher number of AMPs than InRCA ([Figure 6L](#fig6){ref-type="fig"} and [Figure 6--figure supplement 1](#fig6s1){ref-type="fig"}) we cannot exclude a possibility that Notch also acts in an InR-independent way."

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\] *1) On the one hand, the authors use the expression from the m6 enhancer (m6-GFP) expression to argue that Notch is active in the AMPs, but then they now argue that the expression from the same enhancer (in m6-Gal4) can\'t be reduced when Notch activity is attenuated. These claims are rather contradictory. Most likely there is a simple explanation (perdurance of Gal4 and GFP in the latter?) but this does make the results confusing for the reader (e.g. subheading "Notch acts downstream of the Insulin pathway and regulates the proliferation of AMPs via dMyc" and in the Discussion: \"Here we followed the GFP expression driven by a Notch-responsive element of the m6 gene and found that the Notch pathway was active in dormant AMPs\"). Can they be confident that this is reading out Notch activity at that time? Maybe the enhancer requires Notch for activation but not for maintenance? Given the data they have provided, I suggest that they tone down their statements.*

We agree that because of GaL4/GFP perdurance it is difficult to argue for activation versus maintenance of Notch in quiescent AMPs. As suggested, we toned down our statements in the Results and in the Discussion.

In the Results, the original sentence "As the decrease in AMP numbers in a Notch-RNAi context has not been associated with a reduced level of GFP driven by the same M6 regulatory element ([Figure 4--figure supplement 2](#fig4s2){ref-type="fig"}) we assume that the M6-Gal4 driver stays active in Notch attenuated conditions" now reads: "As the decrease in AMP numbers in a Notch-RNAi context has not been associated with a reduced level of GFP driven by the same m6 regulatory element ([Figure 4--figure supplement 2](#fig4s2){ref-type="fig"}), we hypothesize that a low Notch level is sufficient to maintain m6 activity but we cannot rule out a possibility that perdurance of Gal4 and GFP in larval stages plays role as well."

In the Discussion, the passage "Here we followed the GFP expression driven by a Notch-responsive element of the *m6* gene and found that the Notch pathway was active in dormant AMPs..." now reads: "Here we followed the GFP expression driven by a Notch-responsive element of the *m6* gene and found that dormant AMPs are GFP-positive, which suggests that like in satellite cells, Notch is involved in setting the AMP quiescent state."

*2) Teasing apart the ligand dependent versus ligand independent Notch activity is tricky. The authors discuss in the rebuttal their experiment with the KuzDN, which gives minor effects that they argue should be ignored. But at the same time they place quite a strong emphasis on the role of Deltex despite the fact that the results in this section are confusing and contradictory (e.g. over-expressing and attenuating Deltex have the same effects, likewise Su(dx), likewise kurtz). Given these contrary data, it doesn\'t seem appropriate to make major conclusions about the roles of these factors so I suggest that they remove the scheme from the right hand part of [Figure 8](#fig8){ref-type="fig"} and further moderate their statements about the role of Dx. Altering Deltex activity does influence the AMPS but it is not clear that it is the main effector of the signaling through InR nor the critical regulator of Notch in this context.*

As pointed by the reviewers, the fact that over-expressing and attenuating Deltex, Su(Dx) and Kurtz leads to the similar AMP overproliferation phenotype is surprising even if our interpretation based on stoichiometry of Kurtz and Deltex could explain this paradigm. In consequence, we removed the corresponding scheme from [Figure 8](#fig8){ref-type="fig"} and moderated our statement concerning Deltex and its role as InR effector.

We modified the following sentence in the Results section: "Taken together, this body of evidence points to the conclusion that during AMP reactivation, the Insulin pathway activates Notch in a Deltex and Shrub-involving ligand-independent way". This now reads: "Taken together, this body of evidence suggests that during AMP reactivation, the Insulin pathway activates Notch in a Deltex and Shrub-involving ligand-independent way." *3) [Figure 6--figure supplement 1A](#fig6s1){ref-type="fig"} presents a hypothetical scheme not directly connected to experiments described in the manuscript. It should be removed.*

We agree that the scheme is not related to experimental data but rather to hypotheses that were tested. As suggested, we removed it from [Figure 6--figure supplement 1](#fig6s1){ref-type="fig"}.

[^1]: Sloan-Kettering Institute, Rockefeller Research Labs, New York, United States.

[^2]: These authors contributed equally to this work.
